Effects of Toxic Environmental Contaminants on Voltage-Gated Calcium Channel Function: From Past to Present

Journal of Bioenergetics and Biomembranes

Volumn 35, Issue 6, 2003, Pages 507-532

  Atchison, William D ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Inorganic mercury; Ion channels; Lead; Methylmercury; Nerve terminal function; Neuromuscular junction; Neurotoxicity; Polychlorinated biphenyls; Solvents; Synaptosomes

Indexed keywords

ALUMINUM; CALCIUM CHANNEL; CALCIUM ION; CATION; ION CHANNEL; LEAD; MERCURY; MERCURY DERIVATIVE; METAL; METHYLMERCURY; POLYCHLORINATED BIPHENYL; SOLVENT; ZINC;

CHANNEL GATING; CHEMICAL STRUCTURE; ELECTRIC POTENTIAL; HUMAN; ION PERMEABILITY; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NONHUMAN; POLLUTANT; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; SYNAPTOSOME;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL MEMBRANE PERMEABILITY; ENVIRONMENTAL POLLUTANTS; HOMEOSTASIS; HUMANS; ION CHANNEL GATING; LEAD; MEMBRANE POTENTIALS; MERCURY; METALS; POROSITY; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

ANIMALIA; AVES; FURCIFER; LEMUR; PHANER FURCIFER; PRIMATES; STREPSIRHINI; VERTEBRATA;

EID: 0043211858     PISSN: 0145479X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOBB.0000008023.11211.13     Document Type: Short Survey

References (174)

1. Allen, J. E., Gage, P. W., Leaver, D. D., and Leow, A. C. T. (1980). Chem-Biol. Interact. 31, 227-231.
2. Almers, W., and McCleskey, E.W. (1984). J. Physiol. (Lond.) 353, 585-608.
3. Almers, W., and McCleskey, E. W. (1984). J. Physiol. (Lond.) 353, 585-608.
4. Alnaes, E., and Rahamimoff, R. (1974). Nature (Lond.) 247, 478-479.
5. Alnaes, E., and Rahamimoff, R. (1975). J. Physiol. (Lond.) 248, 285-306.
6. Alvarez Maubecin, V., Sanchez, V. N., Rosato Siri, M. D., Cherksey, B. D., Sugimori, M., Llinas, R., and Uchitel, O. D. (1995). J. Neurochem. 64, 2544-2551.
7. Armstrong, C. M., and Neyton, J. (1991). Ann. N.Y. Acad. Sci. 635, 18-25.
8. Atchison, W. D. (1987). J. Pharmacol. Exp. Ther. 241, 131-139.
9. Atchison, W. D. (1988). Neurotoxicol. Teratol. 10:393-416.
10. Atchison, W. D., and Hare, M. F. (1994). FASEB J. 8, 622-629.
11. Atchison, W. D., and Narahashi, T. (1982). Neurotoxicology 3, 37-50.
12. Atchison, W. D., and Narahashi, T. (1984). Neurotoxicology 5, 267-282.
13. Atchison, W. D., Clark, A. W., and Narahashi, T. (1984). In Cellular and Molecular Neurotoxicology, Raven Press, New York, pp. 23-43.
14. Atchison, W. D., Joshi, U., and Thornburg, J. E. (1986). J. Pharmacol. Exp. Ther. 238, 618-624.
15. Audesirk, G. (1985). Prog. Neurobiol. 24, 199-231.
16. Audesirk, G. (1987). Neurotoxicology 8, 579-592.
17. Audesirk, G. (1993). Neurotoxicology 14, 137-148.
18. Audesirk, G., Armstrong, D., van den Maagdenberg, A. M., Atchison, W., Shafer, T., and Fletcher, C. (2000). Environ. Health Perspect. 108, 1215-1218.
19. Audesirk, G., and Audesirk, T. (1989). Neurotoxicology 10, 659-669.
20. Audesirk, G., and Audesirk, T. (1991). Neurotoxicology 12, 519-528.
21. Audesirk, G., and Audesirk, T. (1993). Neurotoxicology 4, 13-26.
22. Bahinski, A., Yatani, A., Mikala, G., Tang, S., Yamamoto, S., and Schwartz, A. (1997). Mol. Cell. Biochem. 166, 125-134.
23. Baker, P. F., Hodgkin, A. L., and Ridgway, E. B. (1971). J. Physiol. (Lond.) 218, 709-755.
24. Bakir, F., Rustam, H., Tikrifi, S., Al-Damluji, S. F., and Shihristani, H. (1980). Postgrad. Med. J. 56, 1-10.
25. Balnave, R. J., and Gage, P. W. (1973). Br J. Pharmacol. 47, 339-352.
26. Bartschat, D. K., and Blaustein, M. P. (1985). J. Physiol. (Lond.) 361, 419-440.
27. Basolo, F., and Pearson, R. G. (1968). Mechanisms of Inorganic Reactions, 2nd ed., Wiley, New York.
28. Benoit, P. R., and Mambrini, J. (1970). J. Physiol. (Lond.) 210, 681-695.
29. Bernal, J., Lee, J. H., Cribbs, L. L., and Perez-Reyes, E. (1997). J. Pharmacol. Exp. Ther. 282, 172-180.
30. Bicalho, A. F., Guatimosim, C., Prado, M. A., Gomez, M. V., and Romano-Silva, M. A. (2002). Neuroscience 113, 115-123.
31. Bickmeyer, U., and Wiegand, H. (1993). Neuroreport. 4, 938-940.
32. Binah, O., Meiri, U., and Rahamimoff, H. (1978). Eur. J. Pharmacol. 51, 453-457.
33. Blioch, Z. L., Glagoleva, I. M., Liberman, E. A., and Nanashev, V. A. (1968). J. Physiol. (Lond.) 119, 11-35.
34. Bowen, J. M. (1971). Can. J. Physiol. Pharmacol. 50, 603-611.
35. Büsselberg, D. (1995). Toxicol. Lett. 82, 255-261.
36. Büsselberg, D., Evans, M. L., Rahmann, H., and Carpenter, D. O. (1991a). Neurotoxicology 12, 733-744.
37. Büsselberg, D., Evans, M. L., Rahmann, H., and Carpenter, D. O. (1991b). J. Neurophysiol. 65, 786-795.
38. Cooper, G. P., and Manalis, R. S. (1983). Neurotoxicology 4, 69-84.
39. Cooper, G. P., and Manalis, R. S. (1984a). Toxicol. Appl. Pharmacol. 74, 411-416.
40. Cooper, G. P., and Manalis, R. S. (1984b). Eur. J. Pharmacol. 99, 251-256.
41. Cooper, G. P., Suszkiw, J. B., and Manalis, R. S. (1984). In Cellular and Molecular Neurotoxicology, Raven Press, New York, pp. 1-21.
42. De Bassio, W. A., Schnitzler, R. M., and Parson, R. L. (1971). J. Neurobiol. 2, 263-278.
43. del Castillo, J., and Engbaek, L. (1954). J. Physiol. (Lond.) 124, 370-384.
44. Dodge, F. A., and Rahamimoff, R. (1967). J. Physiol. (Lond.) 193, 419-432.
45. Drapeau, P., and Blaustein, M. P. (1983). J. Neurosci. 3, 703-713.
46. Eason, K. E., and Aronstam, R. S. (1984). Res. Commun. Chem. Pathol. Pharmacol. 44, 503-506.
47. Ellinor, P. T., Yang, J., Sather, W. A., Zhang, J. F., and Tsien, R. W. (1995). Neuron 15, 1121-1132.
48. Evans, M. L., Büsselberg, D., and Carpenter, D. O. (1991). Neurosci. Lett. 129, 103-106.
49. Forshaw, P. J. (1977). Eur. J. Pharmacol. 42, 371-377.
50. Gawrisch, E., Leonhardt, R., and Büsselberg, D. (1997). Toxicol. Lett. 92, 117-122.
51. Goldstein, G. W. (1992). Pediatr. Ann. 21, 384-388.
52. Gray, E. G., and Whittaker, V. P. (1962). J. Anat. 96, 79-96.
53. Grover, C. A., Jasek, M. C., Frye, G. D., and Griffith, W. H. (1997). Neurotoxicology 18, 179-190.
54. Hajela, R. K., Peng, S.-Q., and Atchison, W. D. (2003). J. Pharmacol. Exp. Ther. 306, 1129-1136.
55. Hare, M. F., and Atchison, W. D. (1995). Toxicol. Appl. Pharmacol. 135, 299-307.
56. Hare, M. F., McGinnis, K. M., and Atchison, W. D. (1993). J. Pharmacol. Exp. Ther. 266, 1626-1635.
57. Hegg, C. C., and Miletic, V. (1996). Brain Res. 738, 333-336.
58. Hegg, C. C., and Miletic, V. (1997). Brain Res. 772, 63-70.
59. Hess, P., and Tsien, R. W. (1984). Nat. (Lond.) 309, 453-456.
60. Hewett, S. J., and Atchison, W. D. (1992a). Toxicol. Appl. Pharmacol. 113, 267-273.
61. Hewett, S. J., and Atchison, W. D. (1992b). Brain Res. 599, 324-332.
62. Hinkle, P. M., Kinsella, P. A., and Osterhoudt, K. C. (1987). J. Biol. Chem. 262, 16333-16337.
63. Hinkle, P. M., and Osborne, M. E. (1994). Toxicol. Appl. Pharmacol. 124, 91-98.
64. Holz, G. G., and Turner, T. J. (1998). Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 119, 201-211.
65. Hubbard, J. I., Jones, S. F., and Landau, E. M. (1968a). J. Physiol. (Lond.) 196, 75-86.
66. Hubbard, J. I., Jones, S. F., and Landau, E. M. (1968b). J. Physiol. (Lond.) 194, 355-380.
67. Huheey, J. E. (1983). Inorganic Chemistry, 3rd ed., Harper & Row, New York.
68. Inglefield, J. R., and Shafer, T. J. (2000). J. Pharmacol. Exp. Ther. 295, 105-113.
69. Jenkinson, D.H. (1957). J. Physiol. (Lond.) 138, 431-444.
70. Juang, M. S. (1976). Toxicol. Appl. Pharmacol. 37, 339-348.
71. Kajimoto, N., and Kirpekar, S. M. (1972). Nature (Lond.) 235, 29-30.
72. Katz, B., Miledi, R. (1969). J. Physiol. (Lond.) 203, 689-706.
73. Kim, M. S., Morii, T., Sun, L. X., Imoto, K., and Mori, Y. (1993). FEBS Lett. 318(2), 145-148.
74. Kita, H., and Van Der Kloot, W. (1973). Nature (Lond.) 245, 52-53.
75. Kuo, C. C., and Hess, P. (1993a). J. Physiol. Physiol. (Lond.) 466, 629-655.
76. Kuo, C. C., and Hess, P. (1993b). J. Physiol. (Lond.) 466, 657-682.
77. Lansman, J. B., Hess, P., and Tsien, R. W. (1986). J. Gen. Physiol. 88, 321-347.
78. Leenders, A. G., van den Maagdenberg, A. M., Lopes da Silva, F. H., Sheng, Z. H., Molenaar, P. C., and Ghijsen, W. E. (2002). Eur. J. Neurosci. 15, 13-18.
79. Lemos, J. R., and Nowycky, M. C. (1989). Neuron 2, 1419-1426.
80. Leonhardt, R., Haas, H., and Büsselberg, D. (1996a). Naunyn Schmiedebergs Arch. Pharmacol. 354, 532-538.
81. Leonhardt, R., Pekel, M., Platt, B., Haas, H. L., and Büsselberg, D. (1996b). Neurotoxicology 17, 85-92.
82. Levesque, P. C., and Atchison, W. D. (1987). Toxicol. Appl. Pharmacol. 87, 315-324.
83. Lippard, S., and Berg, J. (1994). Principles of Bioinorganic Chemistry, University Science Books, Mill Valley, CA.
84. Lux, H. D., Carbone, E., and Zucker, H. (1990). J. Physiol. (Lond.) 430, 159-188.
85. Mallart, A. (1985). J. Physiol. (Lond.) 368, 565-575.
86. Mallart, A., and Brigant, J. L. (1982). J. Physiol. (Lond.) 333, 619-636.
87. Manalis, R. S., and Cooper, G. P. (1973). Nature (Lond.) 243, 354-356.
88. Manalis, R. S., and Cooper, G. P. (1975). Nature (Lond.) 257, 690-691.
89. Manalis, R. S., Cooper, G. P., and Pomeroy, S. L. (1984). Brain Res. 294, 95-109.
90. Marty, M. S., and Atchison, W. D. (1997). Toxicol. Appl. Pharmacol. 147, 319-330.
91. Mazzolini, M., Traverso, S., and Marchetti, C. (2001). J. Neurochem. 79, 407-416.
92. Meiri, U., and Rahamimoff, R. (1972). Science 176, 308-309.
93. Mellow, A. M. (1979). Nature 282, 84-85.
94. Metral, S., Bonneton, C., Hort-Legrand, C., and Reynes, J. (1978). Nature 271, 773-775.
95. Mikala, G., Bahinski, A., Yatani, A., Tang, S., and Schwartz, A. (1993). FEBS Lett. 335, 265-269.
96. Miledi, R. (1966). Nat. (Lond.) 212, 1233-1234.
97. Miledi, R. (1973). Proc. R. Soc. Lond. B. Biol. Sci. 183,421-425.
98. Mintz, I. M., and Bean, B. P. (1993). Neuropharmacology 32, 1161-1169.
99. Miyamoto, M. D. (1983). Brain Res. 267, 375-379.
100. Molgo, J., del Pozo, E., Banos, J. E., and Angaut-Petit, D. (1991). Br. J. Pharmacol. 104, 133-138.
101. Mundy, W. R., Shafer, T. J., Tilson, H. A., and Kodavanti, P. R. (1999). Toxicology 136, 27-39.
102. Nachshen, D. A. (1984). J. Gen. Physiol. 83(6), 941-967.
103. Nachshen, D. A. (1985). J. Physiol. (Lond.) 361, 251-268.
104. Nachshen, D. A., and Blaustein, M. P. (1980). J. Gen. Physiol. 76, 709-728.
105. Nachshen, D. A., and Blaustein, M. P. (1982). J. Gen. Physiol. 79, 1065-1087.
106. Naylor, W. G. (1988). In Calcium Antagonists, Academic Press, Oxford, pp. 23-34.
107. Nelson, M. T. (1986). J. Gen. Physiol. 87, 201-222.
108. Okuda, M., Kunitsugu, I., Kobayakawa, S., and Hobara, T. (2001). J. Toxicol. Sci. 26, 169-176.
109. Oortgiesen, M., van Kleef, R. G., Bajnath, R. B., and Vijverberg, H. P. (1990). Toxicol. Appl. Pharmacol. 103, 165-174.
110. Parent, L., and Gopalakrishnan, M. (1995). Biophys. J. 69, 1801-1813.
111. Pekel, M., Platt, B., and Büsselberg, D. (1993). Brain Res. 632, 121-126.
112. Peng, S., Hajela, R. K., and Atchison, W. D. (2002a). J. Pharmacol. Exp. Ther. 302, 424-432.
113. Peng, S.-Q., Hajela, R. K., and Atchison, W. D. (2002b). Mol. Pharmacol. 62, 1418-1430.
114. Penner, R., and Dreyer, F. (1986). Pflugers Arch. 406, 190-197.
115. Pickett, J. B., and Bornstein, J. C. (1984). Am. J. Physiol. 246, C271-276.
116. Polzin, A., Shipitsin, M., Goi, T., Feig, L. A., and Turner, T. J. (2002). Mol. Cell. Biol. 22, 1714-1722.
117. Reuveny, E., and Narahashi, T. (1991). Brain Res. 545, 312-314.
118. Rossi, A. D., Larsson, O., Manzo, L., Orrenius, S., Vahter, M., Berggren, P. O., and Nicotera, P. (1993). FASEB J. 7, 1507-1514.
119. Rubio, L. S., Garrido, G., Llanes, L., and Alvarez, J. L. (1993). Mol. Cell. Cardiol. 25, 801-813.
120. Rustam, H., Von Burg, R., Amin-Zaki, L., and El Hassani, S. (1975). Arch. Environ. Health. 30, 190-195.
121. Sakamoto, M., Ikegami, N., and Nakano, A. (1996). Pharmacol. Toxicol. 78:193-199.
122. Schanne, F. A., Dowd, T. L., Gupta, R. K., and Rosen, J. F. (1989a). Proc. Natl. Acad. Sci. U.S.A. 86, 5133-5135.
123. Schanne, F. A., Moskal, J. R., and Gupta, R. K. (1989b). Brain Res. 503, 308-311.
124. Shafer, T. J. (1998). Toxicol. Lett. 99, 207-221.
125. Shafer, T. J. (2000). Cell. Mol. Biol. 46, 855-864.
126. Shafer, T. J., and Atchison, W. D. (1989). J. Pharmacol. Exp. Ther. 248, 696-702.
127. Shafer, T. J., and Atchison, W. D. (1991). J. Pharmacol. Exp. Ther. 258, 149-157.
128. Shafer, T. J., and Atchison, W. D. (1992). Brain Res. 595, 215-219.
129. Shafer, T. J., Contreras, M. L., and Atchison, W. D. (1990). Mol. Pharmacol. 38, 102-113.
130. Shafer, T. J., Meacham, C. A., and Barone, S. (2002). Brain Res. Dev. Brain Res. 136, 151-164.
131. Shao, Z., and Suszkiw, J. B. (1991). J. Neurochem. 56, 568-574.
132. Shrivastav, B. B., Brodwick, B. S., and Narahashi, T. (1976). Life Sci. 18, 1077-1081.
133. Silinsky, E. M. (1977). Brit. J. Pharmacol. 61, 691-693.
134. Silinsky, E. M., and Mellow A. M. (1981). In Stable Strontium, Plenum Press, New York, chapter 16.
135. Simons, T. J. (1993). Neurotoxicology. 14, 77-85.
136. Simons, T. J., and Pocock, G. (1987). J. Neurochem. 48, 383-389.
137. Sirois, J. E., and Atchison, W. D. (1996). Neurotoxicology 17, 63-84.
138. Sirois, J. E., and Atchison, W. D. (2000). Toxicol. Appl. Pharmacol. 167, 1-11.
139. Sun, L. R., and Suszkiw, J. B. (1995). J. Neurophysiol. 74, 574-581.
140. Suszkiw, J. B., Murawsky, M. M., and Shi, M. (1989). J. Neurochem. 52, 1260-1269.
141. Suszkiw, J. B., and O'Leary, M. E. (1983). J. Neurochem. 41, 868-873.
142. Suszkiw, J. B., O'Leary, M. E., Murawsky, M. M., and Wang, T. (1986). J. Neurosci. 6, 1349-1357.
143. Suszkiw, J. B., and Toth, G. (1986). Brain Res. 386, 371-378.
144. Suszkiw, J., Toth, G., Murawsky, M., and Cooper, G. P. (1984) Brain Res. 323, 31-46.
145. Szücs, A., Angiello, C., Salanki, J., and Carpenter, D. O. (1997). Cell. Mol. Neurobiol. 17, 273-288.
146. Tang, S., Mikala, G., Bahinski, A., Yatani, A., Varadi, G., and Schwartz, A. (1993). J. Biol. Chem. 268, 13026-13029.
147. Tank, A. W., Ham, L., and Curella, P. (1986). Mol. Pharmacol. 30, 486-496.
148. Taylor, W. R. (1988). J. Physiol. (Lond.) 407, 433-452.
149. Tillar, R., Schafer, T. J., and Woodward, J. J. (2002). Neurochem. Intl. 41, 391-397.
150. Tomizawa, K., Ohta, J., Matsushita, M., Moriwaki, A., Li, S. T., Takei, K., and Matsui, H. (2002). J. Neurosci. 22, 2590-2597.
151. Tomsig, J. L., and Suszkiw, J. B. (1991). Biochem. Biophys. Acta 1069, 197-200.
152. Toth, G. P., Cooper, G. P., and Suszkiw, J. B. (1987). Neurotoxicology 8, 507-516.
153. Traxinger, D. L., and Atchison, W. D. (1987). Toxicol. Appl. Pharmacol. 90, 23-33.
154. Tsien, R. W., Hess, P., McCleskey, E. W., and Rosenberg, R. L. (1987). Annu. Rev. Biophys. Biophys. Chem. 16, 265-290.
155. Tsien, R. W., Lipscombe, D., Madison, D. V., Bley, K. R., and Fox, A. P. (1988). Trends Neurosci. 11, 431-438.
156. Turner, T. J., Adams, M. E., and Dunlap, K. (1992). Science 258, 310-313.
157. Turner, T. J., and Dunlap, K. (1995). Neuropharmacology 34, 1469-1478.
158. Turner, T. J., and Goldin, S. M. (1985). J. Neurosci. 5, 841-849.
159. Turner, T. J., Lampe, R. A., and Dunlap, K. (1995). Mol. Pharmacol. 47, 348-353.
160. Ujihara, H., Sasa, M., and Ban, T. (1995). Jpn. J. Pharmacol. 67, 267-269.
161. Vijverberg, H. P., Oortgiesen, M., Leinders, T., and van Kleef, R. G. (1994). Environ. Health Perspect. 102, 153-158.
162. Wakamori, M., Strobeck, M., Niidome, T., Teramoto, T., Imoto, K., and Mori, Y. (1998). J. Neurophysiol. 79, 622-634.
163. Weakly, J. N. (1973). J. Physiol. (Lond.) 234, 597-612.
164. Weinsberg, F., Bickmeyer, U., and Wiegand, H. (1995). Arch. Toxicol. 69, 191-196.
165. Weller, U., Bernhardt, U., Siemen, D., Dreyer, F., Vogel, W., and Habermann, E. (1985). Naunyn Schmiedebergs Arch. Pharmacol. 330, 77-83.
166. Wiegand, H., Csicsaky, M., and Kramer, U. (1984). Arch. Toxicol. 55, 55-58.
167. Wiegand, H., Lohmann, H., and Chandra, S. V. (1986). Arch. Toxicol. 58, 265-270.
168. Winegar, B. D., and Lansman, J. B. (1990). J. Physiol. (Lond.) 425, 563-578.
169. Xu, Y. F., and Atchison, W. D. (1996). J. Pharmacol. Exp. Ther. 279, 1229-1236.
170. Yan, C. H., and Atchison, W. D. (1996). Toxicologist 30, 187.
171. Yang, J., Ellinor, P. T., Sather, W. A., Zhang, J. F., and Tsien, R. W. (1993). Nat. (Lond.) 366, 158-161.
172. Yatani, A., Bahinski, A., Mikala, G., Yamamoto, S., and Schwartz, A. (1994). Circ. Res. 75, 315-323.
173. Zacharova, D., Hencek, M., Pavelkova, J., and Lipska, E. (1993). Gen. Physiol. Biophys. 12, 183-198.
174. Zhang, J. F., Randall, A. D., Ellinor, P. T., Horne, W. A., Sather, W. A., Tanabe, T., Schwarz, T. L., and Tsien, R. W. (1993). Neuropharmacology 32, 1075-1088.